Cargando…

Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure

This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross‐sections of individuals experiencing an initial health shock at different point in...

Descripción completa

Detalles Bibliográficos
Autores principales: Laudicella, Mauro, Li Donni, Paolo, Olsen, Kim Rose, Gyrd‐Hansen, Dorte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314678/
https://www.ncbi.nlm.nih.gov/pubmed/35362244
http://dx.doi.org/10.1002/hec.4500
_version_ 1784754375086833664
author Laudicella, Mauro
Li Donni, Paolo
Olsen, Kim Rose
Gyrd‐Hansen, Dorte
author_facet Laudicella, Mauro
Li Donni, Paolo
Olsen, Kim Rose
Gyrd‐Hansen, Dorte
author_sort Laudicella, Mauro
collection PubMed
description This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross‐sections of individuals experiencing an initial health shock at different point in time over a 10‐year window and capture the impact of unobservable technology and medical practice to which they are exposed after allowing for differences in health and socioeconomic characteristics. We decompose the residual increment in the part that is due to the effect of delaying time to death, that is, individuals surviving longer after a health shock and thus contributing longer to the demand of care, and the part that is due to increasing intensity of resource use, that is, the basket of services becoming more expensive to allow for the cost of innovation. We use data from the Danish National Health System that offers universal coverage and is free of charge at the point of access. We find that technological progress and change in medical practice can explain about 60% of the increment of HCE, in line with macroeconomic studies that traditionally investigate this subject.
format Online
Article
Text
id pubmed-9314678
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93146782022-07-30 Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure Laudicella, Mauro Li Donni, Paolo Olsen, Kim Rose Gyrd‐Hansen, Dorte Health Econ Research Articles This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross‐sections of individuals experiencing an initial health shock at different point in time over a 10‐year window and capture the impact of unobservable technology and medical practice to which they are exposed after allowing for differences in health and socioeconomic characteristics. We decompose the residual increment in the part that is due to the effect of delaying time to death, that is, individuals surviving longer after a health shock and thus contributing longer to the demand of care, and the part that is due to increasing intensity of resource use, that is, the basket of services becoming more expensive to allow for the cost of innovation. We use data from the Danish National Health System that offers universal coverage and is free of charge at the point of access. We find that technological progress and change in medical practice can explain about 60% of the increment of HCE, in line with macroeconomic studies that traditionally investigate this subject. John Wiley and Sons Inc. 2022-03-31 2022-06 /pmc/articles/PMC9314678/ /pubmed/35362244 http://dx.doi.org/10.1002/hec.4500 Text en © 2022 The Authors. Health Economics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Laudicella, Mauro
Li Donni, Paolo
Olsen, Kim Rose
Gyrd‐Hansen, Dorte
Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
title Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
title_full Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
title_fullStr Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
title_full_unstemmed Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
title_short Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
title_sort age, morbidity, or something else? a residual approach using microdata to measure the impact of technological progress on health care expenditure
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314678/
https://www.ncbi.nlm.nih.gov/pubmed/35362244
http://dx.doi.org/10.1002/hec.4500
work_keys_str_mv AT laudicellamauro agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure
AT lidonnipaolo agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure
AT olsenkimrose agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure
AT gyrdhansendorte agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure